|
|
|
Volumn 13, Issue 7 SUPPL., 1999, Pages 74-76
|
|
UFT/oral calcium folinate plus weekly paclitaxel for metastatic breast cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALKYLATING AGENT;
ANTHRACYCLINE;
ANTINEOPLASTIC AGENT;
FOLINATE CALCIUM;
ORZEL;
PACLITAXEL;
UFT;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC ACTIVITY;
BLEEDING;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE CALCULATION;
DRUG TOLERABILITY;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
METASTASIS;
NEUTROPENIA;
ORAL DRUG ADMINISTRATION;
OVARY CANCER;
PHASE 1 CLINICAL TRIAL;
ADMINISTRATION, ORAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
LEUCOVORIN;
NEOPLASM METASTASIS;
PACLITAXEL;
RETROSPECTIVE STUDIES;
TEGAFUR;
TREATMENT OUTCOME;
URACIL;
|
|
EID: 0032811483
PISSN: 08909091
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (14)
|
